Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that Sabrina Martucci Johnson, Founder, President and Chief Executive Officer of Daré Bioscience, is scheduled to present at Stifel’s 2026 Healthcare Conference happening November 10 – 12, 2026 in New York, New York.
Presentation Details
- Presenter: Sabrina Martucci Johnson, Founder, President and Chief Executive Officer
- Date: Wednesday, November 11, 2026
- Time: 11:20 a.m.–11:50 a.m. ET
- Location: Lotte New York Palace Hotel, 5th Floor – Hubbard
- Live Webcast: Access here
During the presentation, Ms. Johnson will discuss Daré Bioscience’s women’s health portfolio, commercial strategy and clinical pipeline, including the Company’s progress in advancing innovative solutions to address unmet needs in women’s health. Ms. Johnson’s presentation will be webcast live and publicly accessible via the link provided above.
Following the Company’s presentation, a webcast replay will be made available for on-demand viewing and can be accessed through the Presentations, Events & Webcasts page of the Investors section of the Company’s website (darebioscience.com). The presentation will be accessible for 90 days.
ABOUT DARÉ BIOSCIENCE, INC.
Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré Bioscience advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré Bioscience is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré Bioscience is working to change that. Learn more at darebioscience.com.
Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com
Source: Daré Bioscience, Inc.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
It’s Been a Long Time Since Bonds Looked This Good
United States